Global Schistosomiasis Pipeline Guide for Drugs In Development, 2021 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Aug 23, 2021--
The “Schistosomiasis (Infectious Disease) - Drugs In Development, 2021” report has been added to ResearchAndMarkets.com’s offering.
The guide provides comprehensive information on the therapeutics under development for Schistosomiasis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the publisher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Scope of the report:
- The pipeline guide provides a snapshot of the global therapeutic landscape of Schistosomiasis (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Schistosomiasis (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Schistosomiasis (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Schistosomiasis (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Schistosomiasis (Infectious Disease)
- Merck KGaA
- Pai Life Sciences Inc
- Tongli Biomedical Co Ltd
- Villya Pharmaceuticals
Key Topics Covered:
- Schistosomiasis - Overview
- Pipeline Overview
- Schistosomiasis - Therapeutics Assessment
- Schistosomiasis - Companies Involved in Therapeutics Development
- Schistosomiasis - Dormant Projects
- Schistosomiasis - Product Development Milestones
- Featured News & Press Releases
For more information about this report visit https://www.researchandmarkets.com/r/qeu8k1
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com:https://www.businesswire.com/news/home/20210823005439/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: INFECTIOUS DISEASES PHARMACEUTICAL HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2021.
PUB: 08/23/2021 10:47 AM/DISC: 08/23/2021 10:47 AM